Cellebrite DI Q1 2026 EPS Tops Expectations by 20.0%, Revenue Up 19% - AlphaStreet

Solid beat. Cellebrite DI Ltd. (NASDAQ:CLBT) delivered Q1 2026 non-GAAP diluted earnings per share of $0.12, surpassing the $0.10 consensus by 20.0%. Revenu... AlphaStreet Newsdesk powered by AlphaStreet Intelligence CLBT | EPS $0.12 vs $0.10 est (+20.0%) | Rev $128.3M | Net Income $10.9M Stock $12.10 (-5.0%) Solid beat. Cellebrite DI Ltd. (NASDAQ:CLBT) delivered Q1 2026 non-GAAP diluted earnings per share of $0.12, surpassing the $0.10 consensus by 20.0%. Revenue totaled $128.3M for the quarter, representing a 19.0% increase from the $107.5M recorded in Q1 2025. The digital intelligence software provider demonstrated strong momentum in its subscription model while net income reached $30.6M for the quarter. Subscription strength. The quality of this beat appears robust, driven by underlying revenue expansion rather than cost management alone. Subscription services led with $96.5M in revenue, up 25.8% year-over-year, highlighting successful migration toward recurring revenue streams that typically command premium valuations in the software infrastructure sector. Total Annual Recurring Revenue (ARR) was $493 for the quarter, providing visibility into future performance. The subscription growth substantially outpaced overall revenue expansion, suggesting the company is executing on its strategic shift toward more predictable, higher-margin revenue streams. Revenue-driven performance. The 19.0% top-line growth demonstrates that Cellebrite is capturing share in the digital forensics and investigative analytics market. With net income reaching $30.6M on revenue of $128.3M, the company is translating growth into meaningful profitability while continuing to invest in product development and market expansion. This balance between growth and profitability positions the company favorably compared to many software peers still prioritizing growth over earnings. Market pullback. Despite the earnings beat, shares declined 5.0% to $12.10, suggesting investors may have been anticipating stronger results or expressing concern about factors not reflected in the quarterly numbers. This disconnect between operational performance and stock price reaction creates a potential opportunity for investors who believe the company’s subscription momentum can sustain. Wall Street consensus stands at 9 buy, 1 hold, 0 sell, indicating strong conviction among analysts covering the stock that the current valuation presents an attractive entry point. Institutional perspective. For buy-side investors, the key consideration is whether subscription services can maintain the 25.8% growth trajectory while the company continues expanding profitability. The software infrastructure sector typically rewards companies demonstrating both revenue acceleration and operating leverage, which Cellebrite appears to be delivering. The analyst community’s bullish stance, with no sell ratings, suggests the investment narrative remains intact despite today’s stock price weakness. What to Watch: Monitor whether subscription services can sustain growth above 25% in upcoming quarters, as this metric will determine whether Cellebrite can command a premium valuation multiple among software infrastructure peers. The disconnect between operational performance and today’s stock reaction warrants attention to management commentary on competitive dynamics and pipeline trends. This content is for informational purposes only and should not be considered investment advice. AlphaStreet Intelligence analyzes financial data using AI to deliver fast and accurate market information. Human editors verify content. Tags: #Cellebrite DI Ltd. #CLBT #earnings Related Articles Schneider National Jumps 7.2% Amid Sector-Wide Rally MP Materials Drops 6.2% Amid Sector-Wide Selling Forum Markets Releases Q1 2026 Financial Results